Tag: COVID-19


Vaccines Offer ‘Light at the End of the Tunnel’ in Fighting COVID-19, CDC Director Says

|

  Centers for Disease Control and Prevention Director Robert Redfield, MD, said the next few months of the pandemic will be probably the worst in the history of public health in the United States. However, vaccines on the horizon provide a “light at the end of the tunnel” in the battle against COVID-19. During a… Read More


UTHSC Study Finds COVID-19 Hindering Academic Productivity of U.S. Faculty with Very Young Children

|

The academic productivity of higher education faculty In the United States in the science, technology, engineering, mathematics, and medicine (STEMM) fields with very young children suffered as a result of the stay-at-home orders during the early months of the coronavirus pandemic, according to a new study by researchers at the University of Tennessee Health Science… Read More


Chancellor Schwab Says UTHSC Has Stood Strong in Face of Pandemic

|

In his 2019-2020 State of the University Address, Chancellor Steve J. Schwab, MD, Monday said the University of Tennessee Health Science Center is “weathering COVID in a lean, but strong fashion.” Speaking via Zoom in his 11th-annual State of the University Address, the chancellor said the university has “maintained our budget, maintained our workforce, and… Read More


UTHSC, Regional One Health Partner on Post-COVID-19 Clinic

|

The University of Tennessee Health Science Center and Regional One Health have established a post-COVID-19 clinic to provide specialized outpatient follow-up care to individuals who have tested positive for the virus and may be experiencing long-term symptoms after recovery. The clinic will also be available to individuals who have tested positive for COVID-19 and are… Read More


UTHSC Researchers Identify Three Drugs As Possible Therapeutics for COVID-19

|
Colleen Jonsson, PhD

Researchers at the University of Tennessee Health Science Center working with colleagues at the University of New Mexico have identified three drugs, already approved for other uses in humans, as possible therapeutics for COVID-19, the illness caused by the SARS-CoV-2 virus. Based on virtual and in vitro antiviral screening that began in the earlier months of… Read More


UTHSC and Regional One Health Collaborate to Bring Promising COVID-19 Treatment Clinical Trial to Memphis

|

The University of Tennessee Health Science Center and Regional One Health today are announcing that they are partnering on a clinical trial program including two late-stage clinical trials evaluating Regeneron’s REGN-COV2, the company’s investigational two-antibody cocktail for the treatment and prevention of COVID-19. Leading the efforts are John Jefferies, MD, MPH, FAAP, FACC, FAHA, FHFSA,… Read More


Transplant Patients in ICU at No Greater Risk of Death from COVID-19 Than Non-Transplant Patients, Analysis by UTHSC Physicians Shows

|

A national multicenter study that includes a data analysis component by physicians from the University of Tennessee Health Science Center determined that patients who have undergone solid-organ transplants do not have a higher risk of death than those without transplants when admitted to an intensive care unit with a COVID-19 diagnosis. The “Study of the… Read More


Chief Medical Officer for Alternate-Care COVID-19 Hospital an Experienced Pulmonologist and Critical Care Physician

|

For Amik Sodhi, MD, MPH, the coronavirus pandemic has been a crash course in battling an unprecedented adversary. A pulmonologist and interim chief of the Division of Pulmonary, Critical Care and Sleep Medicine at the University of Tennessee Health Science Center, Dr. Sodhi and her colleagues have for the past few months been front and… Read More